3-V Biosciences, Inc.

3-V Biosciences, Inc.

3-V Biosciences, Inc.

Date Founded



3715 Haven Avenue,Suite 220,Menlo Park, CA 94025

Type of Company


Employees (Worldwide)

11 - 50


Holding Companies

Company Description

3-V Biosciences, Inc. discovers and develops novel therapeutics for the treatment of infectious diseases. It evaluates TVB-2640 as monotherapy and in combination with paclitaxel in a Phase 1 clinical trial for the treatment of solid tumors, including non-small cell lung cancer (NSCLC), breast cancer and ovarian cancer. The company was founded in 2006 and is headquartered in Menlo Park, CA.

Contact Data
Trying to get in touch with decision makers at 3-V Biosciences, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Executive Officer

Chief Financial Officer

Chief Medical Officer

Vice President-Biology




Board of Directors

General Partner, Washington DC at New Enterprise Associates

Managing Director at Westlake Village BioPartners

Former President-Research & Development at MedImmune LLC

Founder at Ascletis Pharma, Inc.

Co-Founder at TESARO, Inc.

Executive Chairman at Maverix Biomics, Inc.

Chief Executive Officer at 3-V Biosciences, Inc.

Member, Board of Directors at 3-V Biosciences, Inc.

Principal, Washington DC at New Enterprise Associates

Paths to 3-V Biosciences, Inc.
Potential Connections via
Relationship Science
3-V Biosciences, Inc.
Recent Transactions
Details Hidden

3-V Biosciences, Inc. raised money in a private placement transaction

Details Hidden

3-V Biosciences, Inc. raised money in a private placement transaction

Details Hidden

3-V Biosciences, Inc. raised money in a private placement transaction

Details Hidden

Kleiner Perkins Caufield & Byers (KPCB) focuses on investments in the life sciences, biodefense, green technology, information technology and companies with new technologies related to the iPhone and iPod touchpad platform.The firm's information technology investments focus on the consumer, enterprise, semiconductors, security and communications industries. They invest primarily in early-stage ventures that are incubating new companies with proven entrepreneurs and good ideas.KPCB's life sciences investments include medical devices, drugs, vaccines, personalized medicine, diagnostics and healthcare information technology and services. Their pandemic and biodefense investment initiative focuses on investments in companies with innovations in disease surveillance, rapid diagnostics, new vaccine technology, portable and less expensive manufacturing of vaccines and new antiviral drugs.The firm's iFund invests in market-changing ideas and products that extend the iPhone and iPod touch platform. The Fund invests across all sizes and stages. KPCB targets investments in companies that are developing applications, services and components. Their specific areas of interest include: location-based services, social networking, eCommerce (including advertising and payments), communication and entertainment.

Details Hidden

Ascletis Pharma, Inc. operates as biotechnology firm to test the waters. The company was founded by Jinzi J. Wu and is headquartered in Grand Cayman, Cayman Islands.

Details Hidden

New Enterprise Associates (NEA) focuses on investments in the technology and healthcare sectors. The firm's investment strategy spans all stages of a company's growth, from seeding innovations in emerging markets to funding early-stage companies in high-growth markets to fueling the growth of market leaders. NEA actively invests in emerging markets, with emphasis on India and China.NEA's investments in the healthcare sector focus on companies that address unmet or underserved clinical needs and that combine improved clinical outcomes with lower costs to the market. The firm targets three areas including biopharmaceuticals, medical devices and healthcare services. The firm has a history of partnering with companies that have pioneered transformative innovations in healthcare, such as balloon angioplasty and laparoscopic surgeryWithin the technology sector, NEA focuses on investments in the electronics, consumer technology, enterprise mobility, virtualization, tech-enabled services, SaaS and cloud computing industries.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by 3-V Biosciences, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of 3-V Biosciences, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and 3-V Biosciences, Inc..